secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001193125-26-102178
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics adopts exclusive federal forum for securities claims
-----------------------------------------------------------------------

- Board approved second amended and restated bylaws effective March 6, 2026.
- New exclusive forum provision requires securities law claims to be brought in federal district courts unless company consents otherwise.
- Amendment covers claims under Securities Act of 1933 and Exchange Act of 1934.
- No other material changes to bylaws were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000119312526102178/0001193125-26-102178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000119312526102178/rlay-20260306.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-102178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer